20-07-2026

Almaviva, an Italian digital innovation group, has been awarded the tender issued by Agenas for the “Supply of Telerehabilitation Systems”, acting under a temporary-consortium mandate with BTS Bioengineering, an Italian company specialized in motion analysis and home-based telerehabilitation systems. The contract is a three-year Framework Agreement worth approximately €10 million, under which healthcare organizations will begin procuring these systems through the activation of specific implementation contracts.

The outcome of the tender recognizes the path Almaviva has pursued in recent years, driven by innovation and specialization in telerehabilitation solutions based on advanced technologies that integrate augmented reality, artificial intelligence, and IoT, thanks to the Helios.Rehab platform. This leadership position has been strengthened and validated through important scientific partnerships, such as the one with Villa Beretta, which have demonstrated how effective telerehabilitation is.

“This outcome confirms the strength of our strategy and reinforces Almaviva’s role as a leading partner in digital innovation for healthcare. The Framework Agreement represents an important opportunity to accelerate the adoption of telerehabilitation systems throughout the country, promoting a model that combines technological innovation, scientific evidence, and economic sustainability,” commented Andrea Leonardo, Healthcare Business Unit Director at Almaviva. “We’ll continue to invest in the development of solutions that support the transformation of treatment pathways and respond to the needs of a constantly evolving healthcare system.  Because we believe that digital technologies, integrated with artificial intelligence, augmented reality, and IoT, can help make rehabilitation more accessible, effective, and sustainable, benefiting patients, healthcare professionals, and the entire healthcare system.”

According to recent estimates, the implementation of telerehabilitation programs could reduce the overall costs of rehabilitation by approximately 30%, thanks to a more efficient use of resources. The benefits – for patients, clinicians, and healthcare expenditures – are driving increasing adoption of these solutions. By the end of 2026, the number of patients using telerehabilitation in Italy could increase by 50%.

It is also for this reason that the national telerehabilitation sector is considered high-growth vertical market, with annual growth estimated at between 12 and 15%.